1. Outcomes of a Pharmacoinvasive Strategy for Successful Versus Failed Fibrinolysis and Primary Percutaneous Intervention in Acute Myocardial Infarction (from the Strategic Reperfusion Early After Myocardial Infarction [STREAM] Study) 
Robert C. Welsh, MD, Frans Van de Werf, MD, PhD, Cynthia M. Westerhout, PhD, Patrick Goldstein, MD, Anthony H. Gershlick, MD, Robert G. Wilcox, MD, Thierry Danays, MD, Erich Bluhmki, PhD, Renato D. Lopes, MD, PhD, Philippe Gabriel Steg, MD, Paul W. Armstrong, MD 
American Journal of Cardiology 
Volume 114, Issue 6, Pages (September 2014)
DOI: /j.amjcard
Copyright © 2014 Elsevier Inc. Terms and Conditions

2. Figure 1
Study cohort. The present report is based on a per-treatment analysis of patients with the disease of interest. No disease of interest (i.e., acute MI) was identified when all the 3 following criteria were met: (1) marked as “normal anatomy of infarct-related artery” by local investigators, (2) troponin and/or creatine kinase-MB ≤2 times upper limit of normal, and (3) no ECG evolution typical of myocardial infarction. Cath = catheterization.
American Journal of Cardiology  , DOI: ( /j.amjcard )
Copyright © 2014 Elsevier Inc. Terms and Conditions

3. Figure 2
Thirty-day composite end point and individual clinical events for rescue and scheduled fibrinolytic-treated patients. The composite end point and individual clinical events at 30 days are presented for rescue versus scheduled angiography. Relative risk and corresponding 95% CIs were adjusted for the TIMI risk score. RR = relative risk.
American Journal of Cardiology  , DOI: ( /j.amjcard )
Copyright © 2014 Elsevier Inc. Terms and Conditions